UCB Ventures
ucbventures.com Direct + LP
UCB Ventures is an evergreen strategic corporate venture fund established in 2017. It makes long-term investments in early stage companies in the US and Europe, focusing on novel therapeutic modalities and platforms.
UCB Ventures is a corporate venture arm headquartered in Brussels, Belgium, founded in 2017. It invests both directly in companies and in funds as a limited partner, from seed to Series A, in next-generation cell and gene therapy, regenerative medicine, cell and tissue homeostasis and RNA modulation.
“We invest in start-ups developing novel therapeutic modalities and platforms/assets that address novel biology in areas adjacent to or even beyond UCB's current therapeutic focus.”
— UCB Ventures, own website
- Layer
- Direct + LP
- Invests in
- US, Europe
- Sectors
- next-generation cell and gene therapy, regenerative medicine, cell and tissue homeostasis, RNA modulation, oligo-based therapeutics, synthetic biology therapeutics
- Founded
- 2017
Where this comes from
Every fact above was read from a page UCB Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.ucbventures.com/name, is_investor, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, founded, status, confidence
- https://www.ucbventures.com/portfolio/layer
Record 12344 · added 2026-09-29 · link last verified not yet · confidence high
Similar investors
- KBC Focus FundCorporate venture · Seed – Growth · Belgium
- Lab BoxCorporate venture · Seed – Growth · Brussels, Belgium
- UCBCorporate venture · Brussels, Belgium
- AqceleratorCorporate venture · Seed – Series A · Aartselaar, Belgium
- FinindusCorporate venture · Seed – Growth · Belgium
- NinepointfiveCorporate venture · Seed – Series B · Antwerp, Belgium